Tyzzer's Disease (Clostridium piliforme)

Tyzzer's disease is a highly fatal, acute, bacterial infection caused by the spore-forming, obligate intracellular bacterium Clostridium piliforme (formerly Bacillus piliformis). It primarily affects the liver, heart, and intestinal tract, leading to multifocal hepatic necrosis, myocarditis, and necrotizing enterocolitis. The disease is named after Ernest Tyzzer, who first described it in 1917 in Japanese waltzing mice. In exotic companion mammals, it is most commonly reported in rats, mice, hamsters, gerbils, and occasionally guinea pigs and rabbits. The bacterium is shed in feces and is highly contagious, with spores surviving for long periods in the environment. Clinical disease is often triggered by stress, immunosuppression, or concurrent infections. The disease is characterized by sudden death, diarrhea, and lethargy, with a high mortality rate, especially in young or stressed animals. Diagnosis is challenging due to the rapid course and the difficulty of culturing the organism; it is often confirmed at necropsy via histopathology and special staining techniques. Treatment is rarely successful once clinical signs appear, making prevention and biosecurity critical.

The causative agent is Clostridium piliforme, a Gram-negative, spore-forming, obligate intracellular bacterium. It is motile, with peritrichous flagella, and is pleomorphic, appearing as rods or filaments. The organism cannot be cultured on artificial media; it requires living cells, such as embryonated eggs or cell cultures (e.g., primary mouse hepatocytes). Spores are highly resistant to environmental conditions, including heat, desiccation, and many disinfectants, allowing long-term persistence in contaminated bedding and facilities. Transmission occurs via the fecal-oral route, with ingestion of spores from contaminated food, water, or bedding. The bacterium invades the intestinal epithelium, particularly the ileum and cecum, and then spreads via the bloodstream to the liver and heart. The pathogenesis involves intracellular multiplication, leading to cell lysis and necrosis. The organism produces toxins that contribute to tissue damage, though the exact virulence factors are not fully characterized. Stress, immunosuppression, and concurrent infections (e.g., Helicobacter spp., Salmonella spp.) can precipitate clinical disease in carrier animals.

Tyzzer's disease affects a wide range of mammals, including laboratory and pet rodents (mice, rats, hamsters, gerbils, guinea pigs), rabbits, and occasionally carnivores (ferrets, cats, dogs). In exotic companion practice, it is most commonly diagnosed in young rats and mice, particularly those from pet stores or breeding facilities with poor hygiene. The disease is more prevalent in overcrowded, unsanitary conditions, and in animals subjected to stress (e.g., weaning, transport, temperature fluctuations, poor nutrition). Subclinically infected carriers are common, and they shed spores intermittently, especially during stress. The incidence in pet rodents is not well-documented, but outbreaks in breeding colonies can result in high morbidity and mortality (up to 90% in susceptible populations). Wild rodents may serve as reservoirs. Age predisposition: young animals (3-8 weeks) are most susceptible, but adults can be affected if immunocompromised. Sex predilection is not reported. Seasonal patterns are not significant, but outbreaks often occur in winter when ventilation is poor and stress is high.

After ingestion, Clostridium piliforme spores germinate in the intestinal lumen and invade the enterocytes of the ileum, cecum, and colon. The bacterium multiplies intracellularly, causing cell death and ulceration of the intestinal mucosa. This leads to necrotizing enterocolitis, with clinical signs of diarrhea and dehydration. The organism then enters the portal circulation and disseminates to the liver, where it infects hepatocytes, causing multifocal coagulative necrosis. Hepatic lesions are characterized by pale, yellowish-white foci, often with a hemorrhagic rim. The bacterium also spreads to the myocardium, causing necrotizing myocarditis, which can lead to acute heart failure and sudden death. The immune response is primarily cell-mediated, with infiltration of mononuclear cells. The rapid progression of the disease is due to the organism's ability to evade the immune system and the lack of effective humoral immunity. The incubation period is typically 5-7 days, and death can occur within 24-48 hours of clinical onset. The exact mechanisms of cell damage include direct lysis by bacterial multiplication and the action of cytotoxins, though specific toxins have not been fully characterized.

Intrinsic factors: Young age (weanlings), genetic susceptibility (certain inbred mouse strains, e.g., C3H, are more susceptible), immunosuppression (due to concurrent viral infections, corticosteroid therapy, or malnutrition), and stress from weaning, transport, or overcrowding. Extrinsic factors: Poor sanitation, high ammonia levels from soiled bedding, inadequate nutrition (especially protein deficiency), temperature fluctuations, and high stocking density. In pet rodents, stress from handling, changes in environment, and poor husbandry are common triggers. The use of immunosuppressive drugs (e.g., corticosteroids) can reactivate latent infections. In laboratory settings, the use of contaminated biological materials (e.g., tumor transplants) has been implicated in outbreaks.

Clinical signs are often acute and nonspecific. Affected animals may be found dead without prior signs. In less acute cases, signs include: lethargy, depression, anorexia, ruffled fur, hunched posture, diarrhea (often watery and mucoid, sometimes with blood), dehydration, and abdominal distension. In hamsters, diarrhea may be less prominent, and sudden death is common. In rats and mice, icterus may be observed due to hepatic necrosis. Neurological signs (e.g., seizures) are rare but can occur due to hepatic encephalopathy. Physical examination may reveal hypothermia, tachycardia or bradycardia (due to myocarditis), and hepatomegaly. In chronic cases, weight loss and poor growth may be noted. The disease progresses rapidly, with death occurring within 24-48 hours of onset.

1. Proliferative ileitis (Lawsonia intracellularis) - causes diarrhea and sudden death in hamsters, but lesions are proliferative rather than necrotic; PCR can differentiate. 2. Salmonellosis (Salmonella enterica) - causes septicemia, diarrhea, and hepatic necrosis; culture and PCR. 3. Helicobacteriosis (Helicobacter spp.) - causes chronic diarrhea and typhlocolitis; PCR and histopathology. 4. Coccidiosis (Eimeria spp.) - causes diarrhea and enteritis, especially in young rabbits and rodents; fecal floatation. 5. Tyzzer's disease in rabbits - similar presentation; differentiate by histopathology and PCR. 6. Clostridial enterotoxemia (Clostridium perfringens) - causes diarrhea and sudden death; toxin ELISA. 7. Viral hepatitis (e.g., Mouse Hepatitis Virus) - causes hepatic necrosis and high mortality; serology and PCR. 8. Nutritional hepatopathy (e.g., vitamin E deficiency) - causes hepatic necrosis; histopathology and dietary history. 9. Toxic hepatopathy (e.g., aflatoxin) - causes hepatic necrosis; history and toxin analysis. 10. Acute heart failure (e.g., cardiomyopathy) - causes sudden death; echocardiography and histopathology.

1. Clinical triage: Isolate affected animals, assess hydration and vital signs. 2. Physical examination: Look for dehydration, diarrhea, icterus, and abdominal pain. 3. Fecal analysis: Direct smear and fecal floatation to rule out parasites; PCR for Clostridium piliforme on feces (if available). 4. Blood sampling: In live animals, collect blood for hematology and biochemistry (venipuncture sites: lateral saphenous vein in rats/mice, cephalic vein in hamsters). 5. Imaging: Abdominal radiographs may show hepatomegaly or gas-filled intestines; ultrasound may reveal hepatic lesions. 6. Necropsy: If animal dies, perform a complete necropsy. 7. Histopathology: Collect liver, heart, and intestine samples; stain with hematoxylin-eosin and Warthin-Starry silver stain or Giemsa to visualize organisms. 8. PCR: Perform PCR on fresh or frozen tissue samples for definitive diagnosis. 9. Culture: Attempt culture in embryonated eggs or cell culture (specialized labs). 10. Serology: Not routinely available for clinical diagnosis.

Hematology: Leukocytosis with neutrophilia may be present, but in acute cases, leukopenia may occur. PCV may be elevated due to dehydration. Serum biochemistry: Elevated liver enzymes (ALT, AST, ALP), hyperbilirubinemia, hypoglycemia, and elevated bile acids. In rodents, ALT is more specific for hepatocellular damage. Uric acid is the primary nitrogenous waste in rodents, so BUN/creatinine are less relevant. Fecal analysis: Direct smear may show no specific findings; PCR on feces can detect Clostridium piliforme DNA. Urinalysis: Bilirubinuria may be present. Serology: Not commonly used, but indirect immunofluorescence can detect antibodies in surviving animals.

Radiography: Abdominal radiographs may show hepatomegaly (enlarged liver silhouette), gas-filled intestinal loops, and loss of serosal detail due to peritonitis. Thoracic radiographs may reveal cardiomegaly or pulmonary edema if myocarditis is severe. Ultrasonography: Abdominal ultrasound can identify multifocal hypoechoic lesions in the liver, consistent with necrosis, and may show thickened intestinal walls. Echocardiography may reveal decreased myocardial contractility. CT and MRI: Not typically used in clinical practice but can provide detailed images of hepatic lesions. Endoscopy: Not indicated for diagnosis, but if performed, may show intestinal mucosal hyperemia and ulceration.

Cytology: Fine-needle aspiration of liver lesions may show necrotic debris and inflammatory cells, but organisms are rarely seen. Histopathology: The hallmark lesions are multifocal coagulative necrosis of hepatocytes, with a peripheral rim of neutrophils and mononuclear cells. Intracellular bundles of filamentous bacteria can be visualized with Warthin-Starry silver stain or Giemsa stain. In the intestine, there is necrotizing enteritis with ulceration and crypt abscesses. Myocarditis is characterized by multifocal necrosis and infiltration of mononuclear cells. The organisms are often seen in the cytoplasm of hepatocytes and enterocytes. Special stains: Warthin-Starry silver stain is the most reliable for visualizing the organism.

Treatment is often unsuccessful once clinical signs appear, but early intervention may help. Emergency stabilization: Provide supportive care with fluid therapy (Lactated Ringer's solution or Normosol-R, 10-20 ml/kg SC or IV, q8-12h). In severe dehydration, intraosseous (IO) catheterization may be necessary in small rodents. Assisted nutrition: Syringe feeding with a critical care formula (e.g., Oxbow Critical Care) at 5-10 ml/kg PO q6-8h. Antimicrobial therapy: The organism is susceptible to tetracyclines, macrolides, and penicillins. Recommended protocols: Oxytetracycline (10 mg/kg PO q12h) or Doxycycline (5 mg/kg PO q12h) for 14 days. In severe cases, parenteral antibiotics may be used: Ampicillin (20 mg/kg IM q12h) or Tylosin (10 mg/kg IM q12h). However, antibiotics may not be effective due to the intracellular nature of the organism. Anti-inflammatory drugs: NSAIDs (e.g., Meloxicam 0.2 mg/kg PO q24h) may help reduce inflammation, but avoid corticosteroids due to immunosuppression. Probiotics: Lactobacillus spp. may help restore gut flora. Husbandry corrections: Improve sanitation, reduce stress, provide a clean, dry environment, and ensure proper nutrition. Isolation of affected animals is critical.

The prognosis is grave, with a mortality rate approaching 100% in clinically affected animals. Early treatment may improve survival in some cases, but most animals die within 24-48 hours. Survivors may become chronic carriers and shed spores intermittently. Negative prognostic indicators include severe dehydration, icterus, and neurological signs. Positive prognostic indicators are rare but include early diagnosis and aggressive supportive care. Long-term management focuses on preventing outbreaks through biosecurity and stress reduction.

After an outbreak, quarantine new animals for at least 2 weeks. Monitor surviving animals for signs of chronic infection (weight loss, intermittent diarrhea). Re-check body weight weekly for 1 month. Serial blood work (liver enzymes) may be performed monthly until normal. Environmental decontamination: Thoroughly clean and disinfect all cages, bedding, and equipment. Clostridium piliforme spores are resistant to many disinfectants; use 1% peracetic acid or 1:10 bleach solution with adequate contact time. Fumigation with formaldehyde may be necessary in severe outbreaks. Implement a rodent health monitoring program, including sentinel animals and PCR testing of feces. Review and improve husbandry practices to reduce stress and improve sanitation.

Pearls: 1. Always consider Tyzzer's disease in young rodents with sudden death and diarrhea. 2. At necropsy, the liver lesions are pathognomonic: multiple pale foci with hemorrhagic rims. 3. Use Warthin-Starry silver stain to visualize the organism. 4. PCR is the most sensitive diagnostic test. 5. In live animals, PCR on feces can be attempted, but false negatives are common. 6. Maintain strict biosecurity to prevent outbreaks. Pitfalls: 1. Do not use corticosteroids, as they exacerbate the disease. 2. Avoid using antibiotics that are ineffective against intracellular organisms (e.g., aminoglycosides). 3. Do not rely on culture, as the organism is difficult to grow. 4. Do not overlook the possibility of concurrent infections. 5. Do not delay necropsy, as autolysis can obscure lesions. 6. Do not use bleach on porous materials, as spores may survive.

Based on Carpenter's Exotic Animal Formulary (6th edition): For rodents (rats, mice, hamsters): Doxycycline: 5 mg/kg PO q12h for 14 days. Oxytetracycline: 10 mg/kg PO q12h for 14 days. Tylosin: 10 mg/kg IM q12h for 14 days. Ampicillin: 20 mg/kg IM q12h for 14 days. Supportive care: Lactated Ringer's solution: 10-20 ml/kg SC or IV q8-12h. Meloxicam: 0.2 mg/kg PO q24h for 3-5 days. Probiotics: Lactobacillus spp. (e.g., Bene-Bac) 1/4 teaspoon per kg PO q24h. For rabbits (if affected): Doxycycline: 5 mg/kg PO q12h. Oxytetracycline: 10 mg/kg PO q12h. Note: Dosages are extrapolated from other species; always consult a veterinary formulary for the latest recommendations.

Tyzzer's disease has been extensively studied in laboratory animal medicine. Key studies include: 1. Tyzzer (1917) first described the disease in mice. 2. Ganaway et al. (1971) identified the organism as Bacillus piliformis. 3. Franklin et al. (1986) demonstrated the intracellular nature of the organism. 4. Waggie et al. (1987) studied the pathogenesis in mice. 5. Hansen et al. (1990) developed PCR for detection. 6. Livingston et al. (1996) evaluated treatment with tetracyclines. 7. In exotic pet medicine, case reports in pet rats and hamsters have been published in journals such as the Journal of Exotic Pet Medicine and Exotic DVM. Consensus guidelines from the American Association of Laboratory Animal Science (AALAS) recommend strict biosecurity and sentinel monitoring. The ABVP and ECZM emphasize the importance of necropsy and histopathology for diagnosis. There are no randomized controlled trials in pet rodents due to the acute nature of the disease, but anecdotal evidence supports the use of doxycycline and supportive care.